Loading...
Maintenance Therapy for NSCLC: Consensus and Controversy
Nowadays, advanced non-small cell lung cancer (NSCLC) is still an incurable disease. However, recent researches on maintenance therapy have led to considerable progress. Recently, pemetrexed and erlotinib have been approved for maintenance chemotherapy by both the U.S. Food and Drug Administration a...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer-Verlag Berlin Heidelberg
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3551304/ https://ncbi.nlm.nih.gov/pubmed/23359213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11670-011-0254-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|